Novo Nordisk Stock Falls After Major Rebrand
Novo Nordisk NYSE:NVO shares fell 2% on Tuesday even after the drugmaker introduced a new brand identity and updated its corporate culture, as an analyst said the changes may need to be supported by a broader strategy.BMO Capital analyst Evan Seigerman kept a Hold rating and a $47 price target on t…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.